There is a moment most wearable device owners recognize. You glance at your wrist, see a stress score of 87 out of 100, and feel your pulse quicken, not from anxiety, but from the nagging suspicion that the number is meaningless. Your step count disagrees with your running app. Your sleep tracker insists you got six hours of deep sleep on a night you remember as fitful and brief. Your heart rate reading spikes to 142 beats per minute while you were sitting quietly eating lunch.
The global wearable technology market has grown into a multibillion-dollar industry. Tens of millions of people now wear some form of health-monitoring device daily, from basic fitness bands to sophisticated smartwatches that promise to detect atrial fibrillation, measure blood oxygen saturation, track stress, estimate glucose trends, and even predict illness before symptoms emerge. The pitch is seductive and, in its broad strokes, not entirely unreasonable. Continuous, passive health monitoring could, in theory, transform preventive medicine. The reality, however, is considerably more complicated.
The Sensor Problem Nobody Wants to Talk About
The foundation of every health wearable is its sensor suite, and that foundation is, in many respects, shakier than manufacturers like to admit. Most consumer wearables rely on photoplethysmography, a technology that uses green, red, or infrared light to detect changes in blood volume beneath the skin. From this signal, devices attempt to derive not just heart rate but also heart rate variability, respiratory rate, blood oxygen levels, and stress markers. The problem is that the original signal is noisy, highly sensitive to motion, skin tone, ambient light, and how snugly the device sits against the wrist.
A widely cited study published in the journal JAMA Cardiology evaluated heart rate accuracy across several popular wrist-worn consumer devices and found that accuracy was best at rest and diminished during exercise, the exact scenario in which accurate data matters most for athletic training. Subsequent research has likewise found that optical heart rate sensors tend to be less accurate during physical activity than at rest.
Blood oxygen monitoring, or SpO2 measurement, became a major selling point during and after the COVID-19 pandemic. Research has raised concerns that optical oxygen sensors can be less accurate on people with darker skin tones. A 2020 study in the New England Journal of Medicine, focused on hospital pulse oximeters rather than consumer wearables, nonetheless helped crystallize a growing concern: optical sensors may perform less accurately on darker skin. The FDA has also taken up pulse oximeter accuracy, and the concern remains relevant to optical sensors in consumer wearables.
The sleep tracking problem is perhaps even more fundamental. Consumer wearables estimate sleep stages primarily through movement detection and heart rate patterns, a method called actigraphy. Clinical sleep science uses polysomnography, which measures brain wave activity directly. Reviews comparing consumer wearables with polysomnography have found that they detect sleep versus wake reasonably well but are considerably less accurate at distinguishing light, deep and REM sleep. These are not minor rounding errors. They are structural limitations of measuring brain states from your wrist.
The Credibility Gap Between Consumer and Clinical
One of the most persistent frustrations around wearables is the ambiguous territory they occupy between consumer electronics and medical devices. Most are regulated as general wellness products rather than medical devices, which means they are not required to meet the same evidentiary standards as a blood pressure cuff or a clinical ECG machine. Manufacturers can market “health insights” without proving those insights are clinically valid.
There are exceptions. The ECG function on Apple Watch received FDA clearance in 2018 for detecting atrial fibrillation, a meaningful clinical achievement. Several subsequent studies have validated this particular feature with reasonable accuracy in specific populations. But the same device also ships with a range of wellness features that do not carry the same evidentiary backing. The result is a device that blends clinically validated features with wellness speculation, presenting everything in the same confident, polished interface.
This conflation matters. When a person sees an alert suggesting an irregular heart rhythm, they may appropriately seek medical attention. When they see a low “readiness score” or a sleep quality rating, they are receiving a number derived from proprietary algorithms that have often not been independently validated or peer-reviewed. The companies treat these scores as trade secrets, which makes external scrutiny impossible.
The core challenge is arguably not the devices but the interpretation layer. Collecting a signal is technically achievable. Translating that signal into actionable, accurate health guidance is a fundamentally harder problem, one that requires clinical validation studies that most consumer wearable makers have not conducted at the necessary scale or rigor.
The Data Privacy Labyrinth
Health data is among the most sensitive personal information a person can generate, and wearables produce it continuously, passively, and at extraordinary granularity. Where that data goes, how it is stored, who can access it, and how it might be used in the future are questions that most consumers have never meaningfully engaged with, often because the answers are buried in terms-of-service documents designed not to be read.
In the United States, health data generated by consumer wearables largely falls outside the protections of HIPAA, which applies to healthcare providers and insurers rather than consumer technology companies. This is not a legal loophole so much as a structural gap: HIPAA was written for a world before passive biometric monitoring existed at scale. The result is that a fitness tracker company may legally share aggregated data with third parties, sell anonymized data sets to researchers or insurers, or use health patterns to inform targeted advertising, depending on the specific terms you agreed to when you activated your device.
Fitbit’s acquisition by Google in 2021 intensified these concerns dramatically. Critics pointed out that combining detailed health and activity data with Google’s advertising ecosystem and search history created a surveillance profile of unusual depth. Google has made public commitments to keep Fitbit health data separate from advertising products.
The situation in Europe is somewhat better, owing to GDPR enforcement, but European regulators have repeatedly flagged wearable data practices as a priority concern. European regulators and privacy advocates have repeatedly raised concerns about how health data from apps and wearables is shared with third parties and transferred outside the EU.
For users who take privacy seriously but still want the functional benefits of health tracking, the landscape requires careful navigation. Devices that store data locally and minimize cloud dependency are a real consideration. A privacy-focused fitness tracker with offline capability offers more control than cloud-dependent ecosystems, though the tradeoff is often reduced analytical sophistication.
The Engagement Trap and Behavioral Backfires
Even setting aside the technical and regulatory problems, wearables face a more fundamental challenge: the gap between measuring behavior and changing it. The implicit promise of health trackers is that awareness generates improvement. If you see how sedentary you are, you will move more. If you see how little deep sleep you get, you will improve your sleep hygiene. If your stress score is perpetually high, you will address it.
The research on this is, at best, mixed. A randomized controlled trial published in JAMA in 2016 found that young adults given a wearable device on top of a standard behavioral weight-loss program lost less weight over two years than those who followed the program without one. More recent studies have found similarly ambivalent results, with wearables sometimes producing short-term behavior change that fades within months as novelty wears off.
There is also a well-documented problem of anxiety and compulsion. Clinicians treating patients with eating disorders or exercise addiction have reported that wearables can reinforce harmful behaviors, providing granular data that obsessive patients use to justify extreme restriction or overexercise. The devices have no context for the person wearing them. A user who exercises five hours a day will receive congratulatory feedback about their activity levels regardless of whether that exercise is part of a pathological pattern.
Even for people without clinical presentations, the constant quantification of bodily experience can have subtle negative effects. “Orthosomnia” is a term coined to describe anxiety about sleep data, and clinicians have described people who become preoccupied with their sleep tracker scores and sleep worse as a result of the monitoring itself. The irony is precise and brutal: the tool meant to improve your rest may be making it worse.
Where Wearables Actually Work
It would be dishonest to write this piece as a pure indictment. There are domains where wearable health technology has delivered genuine, validated value, and acknowledging them is essential for an accurate picture.
Cardiac monitoring may be the clearest success story. The Apple Watch ECG feature has been credited with helping users detect previously unknown atrial fibrillation in reported cases. This is a real clinical contribution, not marketing copy.
For people managing chronic conditions, wearables can serve as accountability tools even when their measurements are imprecise. People with Type 2 diabetes who use continuous glucose monitors, the most medically sophisticated end of the wearable spectrum, have shown improved glycemic control in multiple studies. CGM devices occupy a different regulatory category from basic fitness trackers and are subject to more rigorous validation. A continuous glucose monitor represents the sharper edge of what wearable health technology can deliver when properly validated.
Activity tracking in its simplest form, counting steps and estimating general movement, is reasonably well-validated and has been shown to increase physical activity in some populations when combined with goal-setting. The problem arises when this basic capability is dressed up in the language of comprehensive health analysis.
For serious athletes who want actionable data on training load, recovery, and performance, more sophisticated devices designed specifically for that use case, like dedicated GPS sports watches, perform considerably better than general wellness wearables because they are solving a narrower, more tractable problem. A GPS running watch with heart rate monitor designed for athletic training is a different product category from a fashion-forward wellness device, even if they look superficially similar.
What Has to Change
The path from where wearables are to where they claim to be is not mysterious. It is simply expensive and inconvenient for the companies involved.
First, independent validation needs to become the norm rather than the exception. Regulation is not guaranteed to supply it: in January 2026 the FDA revised its general wellness guidance in a way widely described as relaxing oversight of low-risk wearables, so pressure for independent validation may have to come from researchers, clinicians and consumers as well.
Second, algorithm transparency matters. If a company is going to tell you your “body battery” is at 34 percent, consumers deserve to know what that number means, how it is calculated, and what the error range looks like. Proprietary algorithms that produce health scores without any published methodology are not a feature. They are a liability dressed up as intellectual property.
Third, the federal data privacy framework in the United States needs updating. Health data generated by consumer devices should carry meaningful protections regardless of whether it passes through a hospital system. Several legislative proposals have attempted to address this gap, but none has become federal law as of this writing.
Fourth, and perhaps most importantly, the industry needs to reckon with the difference between engagement and health. Features that generate daily interaction with an app are good for retention metrics. They are not necessarily good for the people wearing the devices. The two goals are sometimes aligned and sometimes in direct conflict.
The wearable health tracker is not a failed technology. It is an immature one, sold at the scale and confidence of a mature one. The gap between the marketing and the reality is not fixed by cynicism, but it is also not closed by enthusiasm. It is closed by rigor: in sensor design, in clinical validation, in regulatory oversight, and in the honest communication of what these devices can and cannot do.
The promise of the wearable is not wrong. Continuous, personalized health monitoring could genuinely shift medicine from reactive to preventive. But promise is not performance, and for millions of people checking their stress scores and sleep summaries each morning, the difference is not academic. It is the difference between a tool and a toy with very serious branding.
As an Amazon Associate, The Rough Idea earns from qualifying purchases.